A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. (Q34145890)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. |
scientific article |
Statements
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes (English)
W Y Lee
K H Yoon
S J Yoo
I K Lee
S H Baik
Y K Kim
M K Lee
K S Park
J Y Park
B S Cha
H W Lee
K W Min
H Y Bae
M J Kim
J A Kim
D K Kim
1 December 2010